A Randomized Placebo-controlled Trial to Evaluate the Safety and Immunogenicitiy of the COVID-19 Vaccine
Condition: COVID-19 Interventions: Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - Low dose; Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - High dose; Biological: One COVID-19 vaccine candidate (TMV-083) administration - High dose; Other: Placebo Sponsors: Institut Pasteur; Themis Bioscience GmbH; Coalition for Epidemic Preparedness Innovations (CEPI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials